J Korean Rheum Assoc.  1999 Mar;6(1):85-90.

Amyopathic Dermatomyositis with Interstitial Lung Disease: A Case Report

Abstract

Amyopathic dermatomyositis is defined by characteristic cutaneous manifestation of dermatomyositis without evidence of muscle involvement. There is no clinical difference between dermatomyositis and amyopathic dermatomyositis. Pulmonary involvement of dermatomyositis is so frequent than aggressive dianostic and therapeutic approach is needed. Early steroid or immunosuppresive treatment in pulmonary involvement of dermatomyositis gets better prognosis. Intravenous immunoglobulin treatment is an effective and safe alternative when the steroid or immunosuppresive treatment is ineffective or intolerable. We are reporting a case of amyopathic dermatomyositis with interstitial lung disease. This patient was improved with intravenous immunoglobulin treatment.

Keyword

Amyopathic dermatomyositis; Interstitial lung disease; Immunoglobulim

MeSH Terms

Dermatomyositis*
Humans
Immunoglobulins
Lung Diseases, Interstitial*
Prognosis
Immunoglobulins
Full Text Links
  • JKRA
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr